As the world adjusts to the reality of a prolonged global pandemic, never has decentralising clinical trials become such a pertinent issue. In an interview with CRO Quanticate, we look at why decentralised trials are becoming more and more important.
About the Speakers:
Fabien Du Fraisse, Vice President, Account Management, Quanticate
Fabien Du Fraisse is the Vice President of Account Management and is responsible for overseeing the key Strategic Accounts at Quanticate. He has extensive experience in both commercial and marketing functions in the Life Science Industry, having held positions at GSK, Unilever, and the UK Government; Fabien Joined Quanticate in 2015. He earned his BSc in Biochemistry from the University of East London.
Deepu Joseph, Vice President and Global Head of Clinical Data Management, Quanticate
Deepu Joseph is currently serving as Vice President and Global Head of Clinical Data Management with Quanticate and has over fifteen years of experience in managing and driving clinical data management operations delivery across major CROs.